Home/Filings/4/0001140361-23-028150
4//SEC Filing

MALLIK AMEET 4

Accession 0001140361-23-028150

CIK 0001604464other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 7:09 PM ET

Size

12.2 KB

Accession

0001140361-23-028150

Insider Transaction Report

Form 4
Period: 2023-05-31
MALLIK AMEET
Director
Transactions
  • Award

    Common Stock

    2023-05-31+57,00077,500 total
  • Award

    Non-Qualified Stock Option (Right to Buy)

    2023-05-31+79,50079,500 total
    Exercise: $1.53Exp: 2033-05-30Common Stock (79,500 underlying)
Footnotes (2)
  • [F1]These restricted stock units shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
  • [F2]The option shall vest on the earlier of May 31, 2024 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.

Issuer

Atara Biotherapeutics, Inc.

CIK 0001604464

Entity typeother

Related Parties

1
  • filerCIK 0001861441

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 7:09 PM ET
Size
12.2 KB